iCell GABANeurons AD APOE E2/E2, 01434

Human iPSC-derived GABA neurons from a Caucasian female (age <18) with an Alzheimer's disease (AD) phenotype (genotype: APOE E2/E2), differentiated from fibroblast-derived iPSCs.

Investigate protective APOE E2 biology with iCell® GABANeurons AD APOE E2/E2, 01434, derived from human induced pluripotent stem cells (iPSCs).

  • Disease relevance With the APOE E2/E2 genotype, these cells support studies of genetic protection against Alzheimer’s disease.
  • Isogenic control Healthy isogenic and APOE E4/E4 iCell GABANeurons, 01434 enable precise interpretation of mutation-specific effects.
  • High purity Stringent quality control ensures each batch provides a predominantly GABAergic neuronal population with >95% purity.
  • Consistent performance Lot-to-lot consistency in phenotype and viability ensures reproducible experiments.
  • Ready-to-use Arriving fully differentiated and cryopreserved, these cells require no further induction or selection steps.
Catalog # E201434

Products

Kits

  • 1 vial Cryopreserved iCell GABANeurons AD APOE E2/E2, 01434
  • 100 ml Neural Base Medium 1
  • 2 ml Neural Supplement A
  • User’s Guide

genetic status

Quantity (Cells Per Vials)

Catalog #

Catalog #:

Alzheimer's Disease differentiated from human iPS cells, frozen

From
$2,545.00

Cells Only

  • 1 vial Cryopreserved iCell GABANeurons AD APOE E2/E2, 01434
  • User’s Guide

genetic status

Quantity (Cells Per Vials)

Catalog #

Catalog #:

Alzheimer's Disease differentiated from human iPS cells, frozen

From
$2,445.00

Product Overview

Apolipoprotein E gene (APOE) is a cholesterol-carrying protein involved in neuronal growth, synaptic maturation, and cellular repair. The composition of APOE, which has three polymorphic alleles (E2, E3, and E4), is a major risk factor Alzheimer’s disease (AD). While APOE E4/E4 has been shown to increase risk of AD, research suggests APOE E2/E2 can confer protection against developing AD. Early research indicates E2 directly impacts amyloid-beta (Aβ) processing (reducing production and deposition) as well as having non-AD related effects on neuronal health via modulating oxidative stress and glucose metabolism pathways.

iCell GABANeurons AD APOE E2/E2 were developed as a cellular model to investigate mechanisms of neuronal protection and discovery of potential therapeutics against AD. The APOE E2/E2 cell line was engineered from the isogenic parental APOE E3/E3 induced pluripotent stem cell line, followed by differentiation into cortical neurons that exhibit a majority GABAergic phenotype.

Features of iCell GABANeurons APOE 2/2:

  • >95% pure neuronal population with a majority of GABAergic (inhibitory) neurons
  • Consistent lot-to-lot GABA phenotypes and cell viability
  • Isogenic iCell GABANeurons, 01434 are available.

View all Alzheimer’s disease cell models here.

Components:

Need Help With This Product?

Our specialists are here to help you find the best product for your application.

Our regular business hours are 9:00am to 5:00pm Central Time (USA)

Need Help With This Product?

Our specialists are here to help you find the best product for your application.

Our regular business hours are 9:00am to 5:00pm Central Time (USA)

Product Highlights

Applications: